November 20,2007
Grassley, Baucus seek information from former drug company executive in Avandia case
WASHINGTON — Sens. Chuck Grassley and Max Baucus have asked a former drug company research executive to provide information to the Senate Committee on Finance about attempts to intimidate a prominent independent scientist who voiced concerns about drug safety.
Dr. Tadataka Yamada was formerly the head of research at GlaxoSmithKline. He now heads the Global Health Program at the Bill and Melinda Gates Foundation. Dr. John Buse was a professor of medicine at the University of North Carolina in 1999, when he expressed concerns about the diabetes drug Avandia, which is made by GlaxoSmithKline.
###
Next Article Previous Article
Recent News
- Wyden Floor Remarks Opposing the Nomination of RFK Jr. to be HHS Secretary
- Wyden Statement Opposing Jamieson Greer's Nomination for U.S. Trade Representative
- Democrats Urge Republicans Against Using Medicaid To Bankroll Tax Cuts For The Rich At The Expense Of Working Families, Seniors And Americans With Disabilities
- Wyden Sounds the Alarm on DOGE Accessing Social Security Systems Containing Americans’ Sensitive Personal and Financial Information
- Responding to Evidence of a Treasury Cover-Up, Wyden Demands Bessent Come Clean on Musk Infiltration of Treasury Payment Systems